Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system

References

• DanielsTRDelgadoTRodriguezJAHelgueraGPenichetMLThe transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancerClin Immunol200612114415816904380
   PubMed Web of Science ®Google Scholar
• DanielsTRDelgadoTHelgueraGPenichetMLThe transferrin receptor part II: targeted delivery of therapeutic agents into cancer cellsClin Immunol200612115917616920030
   PubMed Web of Science ®Google Scholar
• FonsecaCMoreiraJNCiudadCJPedroso de LimaMCSimõesSTargeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cellsEur J Pharm Biopharm20055935936615661509
   PubMed Web of Science ®Google Scholar
• RuefliAASmythMJJohnstoneRWHMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistanceBlood2000952378238510733510
   PubMed Web of Science ®Google Scholar
• MotomuraSMotojiTTakanashiMInhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotidesBlood199891316331719558371
   PubMed Web of Science ®Google Scholar
• CastranovaVKangJHMooreMDPailesWHFrazerDGSchwegler-BerryDInhibition of stimulant-induced activation of phagocytic cells with tetrandrineJ Leukoc Biol1991504124221655939
   PubMed Web of Science ®Google Scholar
• FuLLiangYDengLCharacterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistanceCancer Chemother Pharmacol20045334935614666379
   PubMed Web of Science ®Google Scholar
• ChenBASunQWangXMReversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cellsInt J Nanomedicine2008327728618686787
   PubMed Web of Science ®Google Scholar
• YinQShenJZhangZYuHLiYReversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumorAdv Drug Deliv Rev2013651699171523611952
   PubMed Web of Science ®Google Scholar
• MoghassemiSHadjizadehANano-niosomes as nanoscale drug delivery systems: an illustrated reviewJ Control Release2014185223624747765
   PubMed Web of Science ®Google Scholar
• WangQSunYZhangZDuanYTargeted polymeric therapeutic nanoparticles: design and interactions with hepatocellular carcinomaBiomaterials20155622924025934295
   PubMed Web of Science ®Google Scholar
• WangYLiuPQiuLToxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in miceBiomaterials201334164068407723480957
   PubMed Web of Science ®Google Scholar
• GuoLTChenBALiuRBiocompatibility assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid nanoparticles in vitro and in vivoJ Nanosci Nanotechnol20151537103719
   Google Scholar
• BaoWLiuRWangYPLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathwayInt J Nanomedicine20151055756625609961
   PubMed Web of Science ®Google Scholar
• AhnCHChaeSYBaeYHKimSWSynthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrierJ Control Release20049756757415212887
   PubMed Web of Science ®Google Scholar
• BertramJPJaySMHynesSRRobinsonRCriscioneJMLavikEBFunctionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibilityActa Biomater200952860287119433141
   PubMed Web of Science ®Google Scholar
• BertramJPRauchMFChangKLavikEBUsing polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNFPharm Res201027829119921405
   PubMedGoogle Scholar
• ZhouJPatelTRFuMBertramJPSaltzmanWMOcta-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumorsBiomaterials20123358359122014944
   PubMed Web of Science ®Google Scholar
• ZhangHWangCChenBWangXDaunorubicin-TiO2 nanocomposites as a “smart” pH-responsive drug delivery systemInt J Nanomedicine2012723524222275838
   PubMed Web of Science ®Google Scholar
• RenYZhangHChenBMultifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistanceInt J Nanomedicine201272261226922619560
   PubMed Web of Science ®Google Scholar
• ZhangWLuZKongGHepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIPMol Cancer20141312824886421
   PubMedGoogle Scholar
• WangFZhangWGuoLTGambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cellsCancer Sci20141051063107024890366
   PubMed Web of Science ®Google Scholar
• LiHTakayamaKWangSAddition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expressionCancer Chemother Pharmacol2014741297130525344762
   PubMed Web of Science ®Google Scholar
• ChenYCWenSShangSACuiYLuoBTengGJMagnetic resonance and near-infrared imaging using a novel dual-modality nano-probe for dendritic cell tracking in vivoCytotherapy20141669971024219906
   PubMedGoogle Scholar
• XuXSabanayagamCRHarringtonDAFarach-CarsonMCJiaXA hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeuticsBiomaterials2014353319333024447463
   PubMed Web of Science ®Google Scholar
• MarkmanJLRekechenetskiyAHollerELjubimovaJYNanomedicine therapeutic approaches to overcome cancer drug resistanceAdv Drug Deliv Rev20136513–141866187924120656
   PubMed Web of Science ®Google Scholar
• ZhangXDongYZengXThe effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatmentBiomaterials2014351932194324315578
   PubMed Web of Science ®Google Scholar
• ChenBAYinLChengJEffect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cellsHematology201116243021269564
   PubMed Web of Science ®Google Scholar
• DuWFanYZhengNTransferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug deliveryBiomaterials20133479480623103156
   PubMed Web of Science ®Google Scholar
• LiuGShenHMaoJTransferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluationsACS Appl Mater Interfaces201356909691423883622
   PubMed Web of Science ®Google Scholar
• LindsayJEspostiMDGilmoreAPBcl-2 proteins and mitochondria – specificity in membrane targeting for deathBiochim Biophys Acta2011181353253921056595
   PubMed Web of Science ®Google Scholar
• Gonzalez-CamporaRDavalos-CasanovaGBeato-MorenoABCL-2, TP53 and BAX protein expression in superficial urothelial bladder carcinomaCancer Lett200725029229917126995
   PubMedGoogle Scholar
• SriramojuBKanwarRKKanwarJRNanoformulated cell-penetrating survivin mutant and its dual actionsInt J Nanomedicine201493279329825045261
   PubMed Web of Science ®Google Scholar
• AltieriDCSurvivin, cancer networks and pathway-directed drug discoveryNat Rev Cancer20088617018075512
   PubMed Web of Science ®Google Scholar
• Beedholm-EbsenRvan de WeteringKHardleiTNexøEBorstPMoestrupSKIdentification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalaminBlood20101151632163919897579
   PubMed Web of Science ®Google Scholar
• MurphySHSuzukiKDownesMTumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptorProc Natl Acad Sci U S A2011108171171712221949408
   PubMed Web of Science ®Google Scholar
• BaudVKarinMIs NF-kappaB a good target for cancer therapy? Hopes and pitfallsNat Rev Drug Discov20098334019116625
   PubMed Web of Science ®Google Scholar